Author:
Lu Qi-long,Cirak Sebahattin,Partridge Terence
Subject
Drug Discovery,Molecular Medicine
Reference22 articles.
1. http://www.gsk.com/media/press-releases/2013/gsk-and-prosensa-announce-primary-endpoint-not-met-in-phase-iii-.html
2. Sarepta Therapeutics http://investorrelations.sareptatherapeutics.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=1875187&highlight=
3. In vivo comparison of 2’-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping;Heemskerk;J Gene Med,2009
4. Long-term exon skipping studies with 2’-O-methyl phosphorothioate antisense oligonucleotides in dystrophic mouse models;Tanganyika-de Winter;Mol Ther Nucleic Acids,2012
5. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles;Lu;Proc Natl Acad Sci USA.,2005
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献